The University of Chicago Header Logo

Connection

Hans Schreiber to Neoplasm Micrometastasis

This is a "connection" page, showing publications Hans Schreiber has written about Neoplasm Micrometastasis.
Connection Strength

0.058
  1. Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases. Oncoimmunology. 2025 Dec; 14(1):2514041.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.